Source:http://linkedlifedata.com/resource/pubmed/id/16685165
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2006-5-10
|
| pubmed:abstractText |
The patient was a 66-year-old man who had undergone right upper lobectomy and ND 2a systematic lymph node dissection for lung cancer (M/D adenocarcinoma, p-stage IB) in March of 1999 . On November 2003, postoperative routine chest computed tomography(CT) demonstrated a mass in left S6, and pathological diagnosis revealed P/D squamous cell carcinoma (cT1N2M0, stage IIIA) by CT-guided needle biopsy and mediastinoscopy. At first, we tried two courses of a combination chemotherapy consisting of carboplatin (CBDCA) and paclitaxel every 3 weeks. After 2 courses, the regimen was stopped because of grade 3 arthritis. Then, two courses of CBDCA and gemcitabine were performed. The evaluation of the response was SD by the guidelines of Response Evaluation Criteria in Solid Tumor Groups. Next, gefitinib was orally administered for 6 months but the tumor and mediastinal lymph nodes were growing. In January 2005, oral administration of TS-1 (60 mg/1, 2 courses, 75 mg/3-6 courses) was begun twice a day for 21 consecutive days while cisplatin (60 mg/m(2)) was administered intravenously on day 8. The response was PR (the tumor decreased by 46%), no serious adverse effect was observed, and the patient maintained good quality of life throughout the chemotherapy. This case suggests that TS-1+CDDP chemotherapy may be an effective treatment in patients with advanced lung cancer even after many protocols of chemotherapy.
|
| pubmed:language |
jpn
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Oxonic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Pyridines,
http://linkedlifedata.com/resource/pubmed/chemical/S 1 (combination),
http://linkedlifedata.com/resource/pubmed/chemical/Tegafur
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0385-0684
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
33
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
651-3
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:16685165-Adenocarcinoma,
pubmed-meshheading:16685165-Administration, Oral,
pubmed-meshheading:16685165-Aged,
pubmed-meshheading:16685165-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16685165-Carcinoma, Squamous Cell,
pubmed-meshheading:16685165-Cisplatin,
pubmed-meshheading:16685165-Combined Modality Therapy,
pubmed-meshheading:16685165-Drug Administration Schedule,
pubmed-meshheading:16685165-Drug Combinations,
pubmed-meshheading:16685165-Humans,
pubmed-meshheading:16685165-Lung Neoplasms,
pubmed-meshheading:16685165-Lymph Node Excision,
pubmed-meshheading:16685165-Lymph Nodes,
pubmed-meshheading:16685165-Lymphatic Metastasis,
pubmed-meshheading:16685165-Male,
pubmed-meshheading:16685165-Neoplasm Staging,
pubmed-meshheading:16685165-Neoplasms, Second Primary,
pubmed-meshheading:16685165-Oxonic Acid,
pubmed-meshheading:16685165-Pneumonectomy,
pubmed-meshheading:16685165-Pyridines,
pubmed-meshheading:16685165-Tegafur
|
| pubmed:year |
2006
|
| pubmed:articleTitle |
[A case of a second cancer of metachronous multiple primary non-small cell lung cancer successfully treated with TS-1 and CDDP chemotherapy].
|
| pubmed:affiliation |
Dept. of General Thoracic Surgery, Ishikawa Prefectural Central Hospital.
|
| pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|